Skip to content
Saturday, January 28, 2023
Latest:
  • Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors
  • Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay
  • Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run
  • Eisai Awarded The New Diversity Management Selection 100
  • MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company
Biotech Trends Report

Biotech Trends Report

Know First, Act First

  • New Drugs & Trials
  • General
  • Leaders
  • Technology
  • Global
  • Trending

General

BIOTCHNO General 

Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run

March 31, 2021July 19, 2021 Raza

Canada NewsWire VANCOUVER, BC, March 31, 2021 /CNW/ – Willow Biosciences Inc. (” Willow ” or the ” Company “) (TSX: WLLW) (OTCQX:

Read more
BIOTCHNO General 

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

February 26, 2021May 17, 2021 Raza

Canada NewsWire Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive

Read more
BIOTCHNO General Technology 

MindMed Reaches Agreement to Acquire HealthMode

February 19, 2021April 13, 2021 Bachittar

  Canada NewsWire Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine

Read more
BIOTCHNO General 

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

February 18, 2021April 8, 2021 Desiree Justice

  Canada NewsWire SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIALVANCOUVER, BC,Feb. 18, 2021/CNW/ — BioVaxys Technology

Read more
BIOTCHNO General 

Neptune Wellness Solutions Inc. Announces Termination of “At-The-Market” Offering

February 17, 2021April 8, 2021 Bachittar

  Canada NewsWire LAVAL, QC,Feb. 17, 2021/CNW Telbec/ – Neptune Wellness Solutions, Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT),

Read more
BIOTCHNO General 

AllStar Health Brands Inc. (ALST) Announces Corporate Update and Key Activities for 2021

February 10, 2021April 8, 2021 Bachittar

AllStar Health Brands Inc. (ALST) Announces Corporate Update and Key Activities for 2021 Miami, Florida–(Newsfile Corp. – February 10, 2021)

Read more
BIOTCHNO General 

Lunar New Year Brings Call from CropLife Asia to “Think of and Thank our Farmer Heroes”

February 8, 2021August 4, 2021 Bachittar

Lunar New Year Brings Call from CropLife Asia to “Think of and Thank our Farmer Heroes”   SINGAPORE, Feb 9,

Read more
BIOTCHNO General 

Ultrack Systems Looks Ahead to Q1 2021: Highlights New ELD Product Launch, USA Rollout, and More

December 22, 2020April 8, 2021 vanessa

Ultrack Systems Looks Ahead to Q1 2021: Highlights New ELD Product Launch, USA Rollout, and More  Concord, Ontario–(Newsfile Corp. –

Read more
BIOTCHNO General 

FACT, Inc Changes Ticker Symbol to Reflect Strategic Refocus

December 16, 2020April 8, 2021 vanessa

FACT, Inc Changes Ticker Symbol to Reflect Strategic Refocus  Toronto, Ontario–(Newsfile Corp. – December 16, 2020) –  FACT Inc. (formerly

Read more
BIOTCHNO General 

MindMed Announces $50 Million Bought Deal Public Offering

December 14, 2020April 14, 2021 vanessa

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TOUNITED STATES NEWSWIRE SERVICES OR

Read more
  • ← Previous

New Drugs & Trials

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant
BIOTCHNO New Drugs & Trials 

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant

January 20, 2021April 13, 2021 vanessa

Canada NewsWire MVMD immediately proceeding with selection of Contract Research Organization to conduct adjuvant IPV studyTORONTO,Jan. 20, 2021/CNW/ –Mountain Valley

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
BIOTCHNO New Drugs & Trials 

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease

November 19, 2020April 14, 2021 vanessa
Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
BIOTCHNO New Drugs & Trials 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 8, 2021 vanessa
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
BIOTCHNO New Drugs & Trials 

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

November 7, 2020April 15, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057